Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

20results about How to "Improve lung function" patented technology

Traditional Chinese medicine compound for treating lung-kidney deficiency syndrome stable-phase chronic obstructive pulmonary disease as well as preparation method and application of traditional Chinese medicine compound

The invention discloses a traditional Chinese medicine compound for treating lung-kidney deficiency syndrome stable-phase chronic obstructive pulmonary disease as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine compound comprises the following raw material medicines: 18-22 g of codonopsis pilosula, 9-12 g of morinda officinalis, 12-16 g of radix astragali preparata, 7-11 g of atractylodes macrocephala koidz, 9-11 g of radix rehmanniae preparata, 9-12 g of semen cuscutae, 3-8 g of cassia twig, 10-15 g of salvia miltiorrhiza and 2-6 g of honey-fried ephedra. The traditional Chinese medicine decoction for treating the lung-kidney deficiency syndrome stable-phase chronic obstructive pulmonary disease is obtained by stewing the raw material medicines twice, combining the stewed liquid medicine twice and concentrating the combined liquid medicine. The traditional Chinese medicine compound disclosed by the invention has an excellent treatment effect on the stable-phase chronic obstructive pulmonary disease with the syndrome of deficiency of both lung and kidney, and has better effects of improving exercise tolerance of a patient, relieving clinical symptoms, improving life quality, reducing acute exacerbation times and improving lung functions compared with an existing medicine for treating the disease; meanwhile, the safety is excellent.
Owner:JIANGSU PROVINCIAL HOSPITAL OF TCM

Composite drug-loaded nano preparation and preparation method thereof

The invention relates to the technical field of biological medicine, in particular to a composite drug-loaded nano preparation and a preparation method thereof. The composite drug-loaded nano-preparation comprises a drug-loaded nano-liposome, and a biological enzyme and a myofibroblast targeting ligand which are loaded on the surface of the drug-loaded nano-liposome, the drug-loaded nano-liposome is a nano-liposome in which an anti-fibrosis drug is encapsulated; the mass ratio of the drug-loaded nano-liposome to the biological enzyme to the myofibroblast targeting ligand is (6-15): (0.5-4): (0-3). According to the invention, a composite drug-loaded nano preparation for pulmonary drug delivery in an aerosol inhalation manner is constructed, and the myofibroblast targeting ligand and the biological enzyme are jointly modified on the surface of the drug-loaded nano liposome; and the composite nano preparation (CLG-CS-FAP-NIN) which has myofibroblast targeting and can degrade excessive collagen in an extracellular matrix is prepared and is used for treating the pulmonary fibrosis.
Owner:HARBIN MEDICAL UNIVERSITY

Eucheuma compound for improving lung function and preparation method thereof

The invention provides an eucheuma compound for improving lung function and a preparation method thereof. The eucheuma compound is prepared from the following raw materials in parts by weight: 25 to 35 parts of eucheuma extract, 13 to 17 parts of oyster peptide, 8 to 12 parts of fish collagen peptide, 4 to 6 parts of rhizoma polygonati, 3 to 5 parts of herba cistanche, 2 to 4 parts of semen euryales and 1 to 2 parts of longan. Secondly, the eucheuma extract rich in eucheuma polysaccharide, eucheuma polypeptide and the like is prepared through the technology. The components in the formula of the eucheuma compound have a synergistic effect, and the prepared eucheuma compound can effectively control the lung coefficient and increase of the hydroxyproline content in lung tissue and improve inflammatory infiltration and fibrohyperplasia of the lung. In addition, the compound also inhibits oxidative stress reaction and further inhibits pulmonary fibrosis; the lung lesion is effectively inhibited, the lung function is improved, and the lung health is promoted.
Owner:HAINAN YUNHAO BIOLOGICAL TECH CO LTD

Stem cell preparation for treating pulmonary fibrosis as well as preparation method and application thereof

PendingCN119386048Arestore integrityimprove lung functionPowder deliveryUnknown materialsApoptosisDrug release
The invention discloses a stem cell preparation for treating pulmonary fibrosis. The stem cell preparation is mesenchymal stem cell surface modified nanoparticles. The nanoparticles are ROS (reactive oxygen species) response type lipid polymer hybrid nanoparticles loaded with an anti-fibrosis drug. According to the invention, a hydrophobic drug and a hydrophilic anti-fibrosis drug can be simultaneously loaded through the reductive hybrid nanoparticles, and can be delivered to the lung by utilizing the inflammation targeting capability of stem cells. The polymer in the nanoparticles reacts with active oxygen in the microenvironment to promote drug release, and then the effect of protecting stem cells is achieved. The released medicine can induce dedifferentiation of myofibroblasts and inhibit apoptosis of vascular endothelial cells and endothelial mesenchymal transformation, and the mesenchymal stem cells release growth factors at the same time to promote angiogenesis, reconstruct capillary structures deleted in fibrosis areas, promote lung tissue regeneration and recover lung functions to achieve the effect of treating pulmonary fibrosis.
Owner:CHINA PHARM UNIV

Application of compound in preparation of medicine for preventing, relieving, adjunctively treating or treating lung injury

The invention provides an application of a compound as shown in a formula I, cis-trans isomers, enantiomers, diastereoisomers, racemes, solvates, hydrates or pharmaceutically acceptable salts or prodrugs of the compound in preparation of drugs for prevention, alleviation, adjuvant therapy or treatment of lung injury, and application of the compound in preparation of drugs for prevention, alleviation, adjuvant therapy or treatment of lung injury in preparation of drugs for prevention, alleviation, adjuvant therapy or treatment of lung injury in preparation of drugs for prevention, alleviation, adjuvant therapy or treatment of lung injury. The compound shown in the formula I can obviously reduce proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) of an acute lung injury rat model, improve infiltration of inflammatory cells (including mononuclear / macrophage, lymphocyte and neutrophil) in lung tissues, improve pathological injury of the lung tissues, improve lung functions, and improve the curative effect of the lung. The above results show that the compound represented by the formula I can be used for prevention, alleviation, adjuvant therapy or treatment of lung injury, especially acute lung injury or a combined disease thereof or acute respiratory distress syndrome or a combined disease thereof.
Owner:SHANGHAI SIMR BIOTECHNOLOGY CO LTD

Biregulin recombinant vaccine and application thereof in pulmonary fibrosis treatment

The invention relates to the technical field of immunotherapy, in particular to a regulatory protein recombinant vaccine and application thereof in pulmonary fibrosis treatment. The vaccine contains polypeptide of amphiregulin antigen epitopes, and the amino acid sequence of the vaccine is shown as SEQ ID No. 1. A research result shows that the recombinant vaccine can effectively induce generation of a specific antibody aiming at the AREG protein in a mouse body, so that secretion of the AREG protein and activation of downstream receptors of the AREG protein in the pulmonary fibrosis process are inhibited. By reducing collagen deposition in lung tissue and reducing tissue structure damage, the recombinant vaccine significantly reduces gene expression of fibrosis-related protein, recovers lung functions of pulmonary fibrosis model mice, and inhibits further development of diseases. In addition, the recombinant vaccine can be administered in an aerosol inhalation mode, and has broad-spectrum, efficient and long-term stable expression and good safety. The invention provides a brand-new targeted therapy means for clinical prevention and treatment of pulmonary fibrosis, and shows a wide application prospect.
Owner:QINGDAO UNIV

Traditional Chinese medicine composition, preparation and application thereof

The invention relates to a traditional Chinese medicine composition, a preparation and application thereof. The traditional Chinese medicine composition can be used as a medicine for treating bronchial asthma in an acute attack period and a chronic duration period. The traditional Chinese medicine composition comprises the following raw materials: ephedra, morinda officinalis, astragalus membranaceus, rhizoma atractylodis, rhizoma zingiberis, asarum, schisandra chinensis, pinellia ternate, blackberry lily, divaricate saposhnikovia root and liquorice.
Owner:YANGTZE RIVER PHARMA GRP JIA NGSU LONGFENGTANG TRADITIONAL CHINESE MEDICINE CO LTD

A traditional Chinese medicine compound for treating diabetic pulmonary fibrosis and application thereof

ActiveCN118767024BImprove overall efficacy scoreimprove lung functionFormularyDisease
The application belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine compound for treating pulmonary fibrosis of diabetes and application thereof. The traditional Chinese medicine compound comprises 70-90 parts of Huangqi, 20-40 parts of Danshen, 10-30 parts of Chuanxiong, 20-40 parts of Beishashen and 40-60 parts of Shanyao. The application also discloses application of the traditional Chinese medicine compound in preparation of a medicine for treating pulmonary fibrosis of diabetes of the type of deficiency of both qi and yin and blood stasis. The traditional Chinese medicine compound has reasonable formula, and uses the traditional Chinese medicine theory scientifically. The raw materials are matched according to the principle of monarch, minister, assistant and guide, and the traditional Chinese medicines are synergistically used, so that the traditional Chinese medicine compound can not only supplement deficiency of both qi and yin of diabetes, but also dredge stasis of collaterals of long-term disease, and achieve good clinical test effect by considering both the symptoms and the root cause.
Owner:自贡市第一人民医院

Nano compound for treating bronchial lung dysplasia and preparation method and application thereof

The invention discloses a nano compound for treating bronchial pulmonary dysplasia and a preparation method and application thereof, and the preparation method comprises the following steps: S1, dissolving CuCl2. 2H2O and geniposide in ethanol according to a molar ratio of (3-5): 1 to obtain a reaction liquid I; s2, adjusting the pH value of the reaction solution I in the step S1 to 7 to obtain a reaction solution II for later use; s3, reacting the reaction liquid II in the step S2 at a preset temperature for a preset time to obtain a reaction liquid III for later use; and S4, carrying out centrifugal separation, washing and drying on the reaction liquid III in the step S3 to obtain the nano compound. The prepared nano compound can significantly improve the survival rate and weight of mice, inhibit inflammation and apoptosis caused by high oxygen, promote lung development and improve the lung function of the mice, and it is indicated that the geniposide metal chelate has a potential treatment effect on BPD.
Owner:CHONGQING MEDICAL UNIVERSITY

IAA-PAMAM G4 nano-composite, preparation method and application of IAA-PAMAM G4 nano-composite

The invention provides an IAA (Indoleacetic Acid)-PAMAM (Polyamidoamine) G4 nano-composite. The nano-composite is prepared by combining 3-indoleacetic acid and a fourth-generation polyamide-amine type dendrimer together in an ultrasonic manner. The invention further discloses a preparation method of the IAA-PAMAM G4 nano-composite and application of the IAA-PAMAM G4 nano-composite in prevention or treatment of chronic obstructive pulmonary diseases. According to the IAA-PAMAM G4 nano compound disclosed by the invention, the water solubility and the stability of 3-indoleacetic acid are effectively improved, and the anti-inflammatory effect of the 3-indoleacetic acid is enhanced. The IAA-PAMAM G4 nano-composite disclosed by the invention can directly act on the lung in an aerosol inhalation manner, so that the inflammatory response is relieved, and the lung function is improved. In a mouse chronic obstructive pulmonary disease model, a remarkable effect is shown, the pathological change of chronic obstructive pulmonary diseases is relieved, and the lung function is remarkably improved. In addition, the IAA-PAMAM G4 nano-composite also shows an inhibition effect on expression of inflammatory factors in an in-vitro cell experiment, and the cell inflammation level is reduced.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

A rosmarinic acid premix for alleviating particle-induced lung inflammation in broiler chickens

The invention discloses a rosmarinic acid premix for alleviating broiler pneumonia induced by particles, relates to the technical field of breeding, and is composed of the following raw materials in parts by weight: 600-620 parts of corn, 300-310 parts of soybean meal, 40-50 parts of soybean oil, 10-20 parts of stone powder, 10-20 parts of calcium hydrogen, 1-5 parts of salt, 1-2 parts of lysine, 1-2 parts of methionine, 1-3 parts of 50% choline, 2- 4 parts, 0.1-2.0 parts of complex vitamins; the weight parts of each component in the composite premix are: 30-50g of copper sulfate pentahydrate, 120-150g of ferrous sulfate monohydrate, 150-170g of manganese sulfate monohydrate, 100-120g of zinc sulfate monohydrate, 30-50g of 1% sodium selenite, 10-20g of 1% potassium iodide, 380-400g of medical stone, and 10% rosmarinic acid 100-120g. The formula of the present invention is scientific and reasonable, significantly reduces lung inflammation, inhibits the lung TLR4 signaling pathway, reshapes intestinal flora, and significantly improves the immunity and production performance of broilers. The feed ratio of the present invention has little side effects, no residue, no drug resistance, no environmental pollution, and increased resistance, which further improves the economic benefits of broiler breeding.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY MEDICINE HENAN ACAD OF AGRI SCI

Anti-aging selenium peptide essence nutrient solution and preparation process thereof

The invention relates to an anti-cancer anti-aging selenium peptide essence nutrient solution, and discloses a novel anti-aging selenium peptide essence formula composed of selenium-rich plants, protein peptide-rich animals and special-effect Chinese herbal medicines. The selenium-enriched ampelopsis grossedentata peptide powder is prepared from the following components in proportion: 6mg of plant selenium powder, 30mg of loach ACE protein peptide, 50-60mg of protein peptide, 30-50mg of donkey-hide gelatin peptide, 40-60mg of sea buckthorn fruit powder, 40mg of epigallocatechin and acid ester, 20-40mg of citric acid, 50mg of yeast glucan, 180mg of sorbitol, 80-100mg of whole milk powder, 100mg of burdock root, 30-50mg of alfalfa and 30mg of selenium-enriched ampelopsis grossedentata essence. The traditional Chinese medicine composition helps a human body to remove free radicals, eliminate vivotoxin and resist oxidation, and can effectively inhibit generation of lipid peroxide, prevent blood clots and remove cholesterol; the traditional Chinese medicine composition has the effects of blocking tumor vascularization, resisting cancer and aging, maintaining heart and cerebral vessels, enhancing reproductive function, tonifying kidney, benefiting qi, nourishing yang, benefiting liver, benefiting gallbladder, relieving cough, eliminating phlegm, relieving asthma, improving lung function, promoting tissue regeneration and epithelial tissue healing, moistening skin, maintaining beauty, enhancing human immunity and the like.
Owner:WUHAN BOSHI TECH CO LTD

Traditional Chinese medicine composition capable of eliminating pulmonary nodules and preparation method thereof

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition capable of eliminating pulmonary nodules and a preparation method thereof. The traditional Chinese medicine comprises astragalus membranaceus, codonopsis pilosula, poria cocos, roasted rhizoma atractylodis macrocephalae, honey-fried licorice root and the like, treats both symptoms and root causes, breaks through the limitation of traditional pulmonary nodule treatment, and can accelerate blood flow and condition physique while treating pulmonary nodule; the traditional operation method is broken through by eliminating phlegm, removing dampness, promoting blood circulation to remove blood stasis and softening hardness to dissipate stagnation, and pulmonary nodules caused by imbalance of viscera and imbalance of yin and yang can be adjusted; according to the traditional Chinese medicine composition, a plurality of medicines are combined and comprehensively attacked, the lung function is improved, yin-yang balance is corrected, and nodules are eliminated.
Owner:CHANGZHOU HI TECH DISTRICT MULTIPLE DIMENSION IND TECH INST

A traditional Chinese medicine composition for treating klebsiella pneumoniae pneumonia and a preparation method thereof

The application belongs to the technical field of traditional Chinese medicines, and particularly discloses a traditional Chinese medicine composition for treating Klebsiella pneumoniae pneumonia and a preparation method thereof. The traditional Chinese medicine composition is prepared from eight raw medicinal materials of Zhejiang fritillary bulb, white mulberry bark, Chinese plume-pod seed, dandelion, platycodon root, lily, apricot kernel and poria cocos. The composition has the effects of promoting lung and clearing heat, relieving cough and reducing sputum, and strengthening body resistance and eliminating pathogenic factors. Pharmacodynamic experiments show that the composition has a significant therapeutic effect on Klebsiella pneumoniae pneumonia.
Owner:LUNAN PHARMA GROUP CORPORATION

Traditional Chinese medicine composition and traditional Chinese medicine decoction for preventing and / or treating interstitial lung diseases as well as preparation method and application of traditional Chinese medicine composition and traditional Chinese medicine decoction

The invention provides a traditional Chinese medicine composition and traditional Chinese medicine decoction for preventing and / or treating interstitial lung diseases as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from 25-35 parts of radix astragali, 15-25 parts of radix codonopsis, 10-15 parts of rhizoma atractylodis macrocephalae, 10-20 parts of poria cocos, 10-15 parts of semen armeniacae amarae, 10-15 parts of radix platycodonis, 10-20 parts of radix salviae miltiorrhizae, 10-20 parts of rhizoma chuanxiong, 10-15 parts of radix angelicae sinensis, 4-10 parts of fructus schizandrae and 5-12 parts of radix glycyrrhizae, the radix astragali, the radix codonopsis, the rhizoma atractylodis macrocephalae and the poria cocos are combined to serve as monarch drugs to achieve the effect of tonifying qi, and the radix salviae miltiorrhizae, the radix angelicae sinensis and the rhizoma chuanxiong are combined to serve as ministerial drugs to jointly achieve the effect of promoting blood circulation to remove blood stasis. The radix platycodonis, the semen armeniacae amarae and the fructus schizandrae are combined to serve as adjuvant drugs and jointly achieve the effects of relieving cough and asthma, and the liquorice serves as conductant drugs, has the effect of regulating drug properties and jointly achieves the effects of tonifying qi (lung and spleen), promoting blood circulation to remove blood stasis and relieving cough and asthma, so that the interstitial lung diseases are prevented and / or treated.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV +1

A DNA nanowire breaking through the mucus barrier of chronic obstructive pulmonary disease, a preparation method thereof and application thereof in preparing a medicine for preventing and treating lung infection

PendingCN122499311AAddress multiple obstaclesImplement composite loading
This invention provides a DNA nanowire capable of breaching the mucus barrier in COPD, its preparation method, and its application in the preparation of drugs for preventing and treating lung infections, belonging to the field of nanomedicine technology. The DNA nanowire of this invention utilizes a strongly positively charged antibiotic AMK and a divalent cation Mg²⁺. + The synergistic effect of streptavidin and biotin forms a stable DX tile structure. Subsequently, utilizing the high affinity between streptavidin and biotin, the biotin-modified Biotin-NAC is precisely anchored to the 5' end of the M chain, achieving a combined loading of mucolysis and subsequent immunomodulatory functions. Through a strain-induced azido-alkyne cycloaddition reaction, the DBCO-modified L chain is covalently linked to the azido-modified neutrophil chemotactic peptide Ac-PGP to form a stable triazole structure, endowing the platform with chemotactic ability for CXCR2-overexpressing neutrophils. The DNA nanowires of this invention can effectively prevent and treat lung infections in COPD patients.
Owner:HAINAN MEDICAL UNIV

Use of 1-o-acetylbungeunic acid

PendingCN122272561Aexert antioxidant propertiesExert dual anti-inflammatory effectsNew medicationsALI - Acute lung injury
This invention provides an application of 1-O-acetyl-Inula japonica lactone, which is used to prepare drugs for improving acute lung injury. This invention utilizes network pharmacology, molecular docking, and molecular dynamics simulations to analyze that the Keap1-Nrf2 signaling pathway is a key potential target for Inula japonica in treating acute lung injury. The characteristic component of Inula japonica, 1-O-acetyl-Inula japonica lactone, exerts antioxidant and anti-inflammatory effects by targeting Keap1 and activating the Nrf2 signaling pathway. This invention provides important evidence for the application and new drug development of 1-O-acetyl-Inula japonica lactone.
Owner:GANSU UNIV OF CHINESE MEDICINE

Composition comprising lactic acid bacteria for treating respiratory or inflammatory diseases caused by fine dust stimulation

The present disclosure provides a novel strain of Lactobacillus plantarum GCWB1001, Pediococcus acidilactici GCWB1085, or Lactobacillus rhamnosus GCWB1156, wherein the Lactobacillus plantarum GCWB1001, the Pediococcus acidilactici GCWB1085, the Pediococcus acidilactici GCWB1085, the Lactobacillus rhamnosus GCWB1156, the Lactobacillus plantarum GCWB1001, the Pediococcus acidilactici GCWB1085, the Lactobacillus rhamnosus GCWB1156 having a preservation number KCCM12698P, and the Furthermore, a pharmaceutical composition, a health-care functional food composition and a probiotic are provided, each comprising any one of the novel strains and having an effect of treating or alleviating inflammatory diseases or respiratory diseases.
Owner:GREEN CROSS HEALTH SCI

Application of human umbilical cord mesenchymal stem cell exosome in promotion of lung development and verification method

The invention discloses application of a human umbilical cord mesenchymal stem cell exosome in promotion of lung development and a verification method, and relates to the technical field of biological medicine.The key point of the technical scheme is that the human umbilical cord mesenchymal stem cell exosome remarkably promotes the pulmonary alveolation process and improves the lung structure and function through rich Wnt5a, so that the lung development is promoted, and the lung development is promoted. The morbidity of bronchial lung dysplasia of premature infants is reduced; by activating a Wnt5a / ROCK1 pathway, the exosome enhances differentiation and self-repairing capabilities of alveolar epithelial cells, accelerates synthesis of alveolar surfactants, and improves lung functions and stability; as a biological treatment means, the exosome is high in safety and low in immunogenicity, side effects and complications of drugs are reduced, and clinical transformation potential for treating lung dysplasia of premature infants is shown.
Owner:THE WEST CHINA SECOND UNIV HOSPITAL OF SICHUAN